Novartis executive sold shares before drug data manipulation made public
August 18, 2019 at 12:18 PM EDT
An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated.